Under an NIH grant, the firm plans to develop its Chicago method to analyze fecal metagenomic samples without relying on first culturing the bacteria.

The FDA and an academic research consortium have released a framework for communicating high-throughput sequencing computations and data analysis.

Researchers found variants associated with coronary artery disease and migraine risk at three loci in a genome-wide association study, with opposing directional effects at two index SNPs.

The researchers found disease-related signatures in the immune repertoire of affected patients as well as changes associated with treatment.

According to Slate, some people prefer not to know their genetic risk of certain diseases.

Technology Review notes that states like Maryland and New York limit direct-to-consumer genetic testing.

Women with BRCA1 or BRCA2 mutations tell the Washington Post how learning their status has affected their life choices.

In Science this week: ancient African genome sequences, Zika virus mutation linked to microcephaly, and more.

OnRamp BioInformatics has introduced Rosalind, a genomics analysis platform aimed specifically at life sciences researchers. The San Diego-based company said that the product, named after early DNA researcher Rosalind Franklin, is meant to alleviate backlogs caused by a global shortage of bioinformaticians. 

The firm said today that it has received all regulatory clearances to close the deal that it first proposed in February 2016.

Mirroring developments in the field more generally, the organization's annual meeting showed a move toward more applied research as well as multi-omic projects.

Spun out of Moffitt Cancer Center, M2Gen and the Total Cancer Care protocols promise rapid advancements in precision medicine, starting with oncology.

With the funding, UTHealth's Wenjin Zheng will form the Data Science and Informatics Core for Cancer Research.

Michael Epplen has been promoted to president of Sunquest Information Systems. Epplen had been serving as chief operating officer of Sunquest as well as president of Atlas Medical, which Sunquest parent company Roper Technologies acquired two years ago. He previously spent five years as CEO of Data Innovations, another company that Roper bought in 2015.

Becton Dickenson announced today that Timothy Ring and David Melcher have joined its board of directors. Ring has served as chairman and CEO of Bard since August 2003. He previously joined Bard in 1992 and has served as VP of human resources, group VP of Bard International, and in additional roles. Ring is also a director of Quest Diagnostics, a trustee for the New Jersey Health Foundation, and a board member for the Advanced Medical Technology Association. Melcher has been president and CEO of the Aerospace Industries Association since 2015. Prior to AIA, Melcher was president and CEO of Exelis, a spinoff of ITT Corporation. In addition to being a director for Bard, Melcher is also a member of the Federal Aviation Administration's NextGen Advisory Committe, providing advice on policy-level issues for US aviation modernization.  

In its suit PacBio alleges that Oxford Nanopore infringes two patents it holds related to nanopore sequencing. 

Many molecularly distinct subgroups emerged from a meta-analysis bringing together more than 1,000 high-grade glioma or diffuse intrinsic pontine glioma cases.

With genetic data for seven Stone and Iron Age individuals, researchers estimate that human populations in southern Africa started diverging more than 260,000 years ago.

Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.

The developers said that their multivariant analysis does a better job than using APOE E4 alone at identifying those at greatest risk of developing Alzheimer's. 

The deal ends an investigation by the SEC into certain accounting practices by Alere's foreign subsidiaries. The company also consented to a cease-and-desist order. 

Researchers used gene editing to remove most of the gluten from bread and durum wheat lines, New Scientist reports.